Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service.
作者信息
Camporota Luigi, Meadows Christopher, Ledot Stephane, Scott Ian, Harvey Christopher, Garcia Miguel, Vuylsteke Alain
机构信息
Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, UK; Division of Asthma, Allergy and Lung Biology, King's College London, London SE1 7EH, UK.
Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, UK.
出版信息
Lancet Respir Med. 2021 Feb;9(2):e16-e17. doi: 10.1016/S2213-2600(20)30581-6. Epub 2021 Jan 8.
Abstract
摘要
相似文献
1
Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service.关于将严重呼吸衰竭患者转诊至英国国家医疗服务体系体外膜肺氧合服务机构并收治入院的共识。
Lancet Respir Med. 2021 Feb;9(2):e16-e17. doi: 10.1016/S2213-2600(20)30581-6. Epub 2021 Jan 8.
2
Successful mobile extracorporeal membrane oxygenator for COVID-19 severe respiratory failure.成功应用体外膜肺氧合移动设备治疗 COVID-19 所致严重呼吸衰竭。
J Card Surg. 2020 Dec;35(12):3655-3657. doi: 10.1111/jocs.15106. Epub 2020 Oct 10.
3
A Patient with COVID-19 Treated with ECMO for 26 Days.一名接受体外膜肺氧合（ECMO）治疗26天的新冠肺炎患者。
J Coll Physicians Surg Pak. 2020 Oct;30(10):171-173. doi: 10.29271/jcpsp.2020.supp2.S171.
4
Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.体外膜肺氧合治疗 COVID-19 合并严重呼吸衰竭患者。
JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.
5
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.成功应用清醒体外膜肺氧合治疗重症新型冠状病毒肺炎患者：一例报告
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
6
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
7
Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy.COVID-19 导致的严重急性呼吸窘迫综合征在妊娠中期使用体外膜肺氧合治疗成功。
BMJ Case Rep. 2021 Feb 4;14(2):e240823. doi: 10.1136/bcr-2020-240823.
8
Surge capacity and updated admission criteria: response of the NHS-commissioned national respiratory extracorporeal membrane oxygenation network to the COVID-19 pandemic.应急能力与更新后的入院标准：英国国家医疗服务体系（NHS）委托的全国呼吸体外膜肺氧合网络对新冠疫情的应对措施
Br J Anaesth. 2020 Sep;125(3):e282-e283. doi: 10.1016/j.bja.2020.06.008. Epub 2020 Jun 10.
9
Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure.接受V-V体外膜肺氧合治疗新型冠状病毒严重急性呼吸衰竭患者的治疗结果。
Pulmonology. 2023 May-Jun;29(3):240-243. doi: 10.1016/j.pulmoe.2023.01.001. Epub 2023 Jan 13.
10
Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic.COVID-19 大流行期间的静脉-静脉体外膜肺氧合分配。
J Crit Care. 2021 Feb;61:221-226. doi: 10.1016/j.jcrc.2020.11.004. Epub 2020 Nov 13.
引用本文的文献
1
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.急性呼吸窘迫综合征的进展：聚焦于异质性、病理生理学和治疗策略。
Signal Transduct Target Ther. 2025 Mar 7;10(1):75. doi: 10.1038/s41392-025-02127-9.
2
The Protective Effects of Sivelestat Sodium on the Basis of Corticosteroid Therapy in Patients With Moderate-to-Severe Acute Respiratory Distress Syndrome.西维来司他钠在中重度急性呼吸窘迫综合征患者糖皮质激素治疗基础上的保护作用
Emerg Med Int. 2025 Feb 12;2025:1824299. doi: 10.1155/emmi/1824299. eCollection 2025.
3
ECMO for Adult Respiratory Failure: A Rapid Review of Clinical and Service Delivery Evidence to Guide Policy in Wales.成人呼吸衰竭的体外膜肺氧合：对临床和服务提供证据的快速回顾，以指导威尔士的政策制定
Semin Cardiothorac Vasc Anesth. 2024 Dec 22;29(3):10892532241309787. doi: 10.1177/10892532241309787.
4
The effects of blood cell salvage on transfusion requirements after decannulation from veno-venous extracorporeal membrane oxygenation: an emulated trial analysis.静脉-静脉体外膜肺氧合撤机后血细胞回收对输血需求的影响：一项模拟试验分析
Crit Care. 2024 Dec 5;28(1):403. doi: 10.1186/s13054-024-05177-7.
5
Extracorporeal membrane oxygenation: unmet needs and perspectives.体外膜肺氧合：未满足的需求与展望
Rheumatol Int. 2024 Dec;44(12):2745-2756. doi: 10.1007/s00296-024-05732-z. Epub 2024 Oct 16.
6
Veno-venous extracorporeal membrane oxygenation in severe acute respiratory failure.静脉-静脉体外膜肺氧合用于严重急性呼吸衰竭
BJA Educ. 2024 Apr;24(4):138-144. doi: 10.1016/j.bjae.2024.01.001. Epub 2024 Feb 1.
7
Clinical effect of high-flow nasal cannula oxygen therapy combined with naloxone on severe respiratory failure in older adult patients: a randomized controlled trial.高流量鼻导管吸氧联合纳洛酮治疗老年重症呼吸衰竭的临床效果：一项随机对照试验
Am J Transl Res. 2023 Nov 15;15(11):6613-6620. eCollection 2023.
8
Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia.肺泡性氧中毒与危重症 SARS-CoV-2 肺炎肺损伤加重。
Med Sci (Basel). 2023 Nov 1;11(4):70. doi: 10.3390/medsci11040070.
9
Critical care and pandemic preparedness and response.重症监护和大流行防范与应对。
Br J Anaesth. 2023 Nov;131(5):847-860. doi: 10.1016/j.bja.2023.07.026. Epub 2023 Sep 14.
10
Comparison of Blood and Blood Product Transfusion in COVID-19 and Non-COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation for Severe Respiratory Failure.COVID-19患者与非COVID-19患者因严重呼吸衰竭需要体外膜肺氧合时血液及血液制品输注情况的比较
J Clin Med. 2023 Jul 13;12(14):4667. doi: 10.3390/jcm12144667.
本文引用的文献
1
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
2
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.体外膜肺氧合治疗 COVID-19 相关严重急性呼吸窘迫综合征的回顾性队列研究。
Lancet Respir Med. 2020 Nov;8(11):1121-1131. doi: 10.1016/S2213-2600(20)30328-3. Epub 2020 Aug 13.
3
Outcomes of the NHS England National Extracorporeal Membrane Oxygenation Service for adults with respiratory failure: a multicentre observational cohort study.英格兰国民保健制度国家体外膜肺氧合服务成人呼吸衰竭的结果：一项多中心观察队列研究。
Br J Anaesth. 2020 Sep;125(3):259-266. doi: 10.1016/j.bja.2020.05.065. Epub 2020 Jul 28.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.地塞米松治疗急性呼吸窘迫综合征：一项多中心、随机对照试验。
Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.
6
Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS.长期低剂量甲泼尼龙治疗对缩短急性呼吸窘迫综合征（ARDS）患者机械通气时间及降低死亡率非常有效。
J Intensive Care. 2018 Aug 24;6:53. doi: 10.1186/s40560-018-0321-9. eCollection 2018.
7
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.体外膜肺氧合治疗严重急性呼吸窘迫综合征。
N Engl J Med. 2018 May 24;378(21):1965-1975. doi: 10.1056/NEJMoa1800385.
8
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.
9
Failure of Noninvasive Ventilation for De Novo Acute Hypoxemic Respiratory Failure: Role of Tidal Volume.新发低氧性呼吸衰竭行无创通气失败：潮气量的作用。
Crit Care Med. 2016 Feb;44(2):282-90. doi: 10.1097/CCM.0000000000001379.
10
High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.经鼻高流量氧疗在急性低氧性呼吸衰竭中的应用。
N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326. Epub 2015 May 17.
Zotero 插件